By Debdeep Gupta | 16 Dec, 2024
Brokerage Radar: Jefferies trims PI Industries target; Goldman Sachs bullish on Aurobindo Pharma
Jefferies On PI IndustriesBuy Call, Target Cut To `4,865/Sh From `5,100/ShFactored In Lower Kumiai Agchem Rev Growth Guidance While Guiding For Lower Growth In Q2Co Sees No Impact On Margin With Raw Material Prices SofteningNew Products Should Drive Growth In FY26Cut FY26/27 Revenues 3%/5% Leading To 4%/5% Cut To FY26/27 EPSProject 10% EPS CAGR Over FY24-27Jefferies On Max Financial ServicesBuy Ca...
Live Comments